SH2D1B and plasma cell myeloma: Thus, SLAMF7 does not have activation or inhibitory signaling function in myeloma cells, due to the lack of EAT-2 to mediate activation and the lack of CD45 to maintain Src family kinases in an active state that is required to phosphorylate SLAMF7 and the inhibitory SHIP-1 phosphatase.